GAMMA Investing’s Tango Therapeutics TNGX Stock Holding History

GAMMA Investing’s Portfolio TNGX Stock Details TNGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$27.7K	Buy	1,111 +248	+29%	+$6.46K	﹤0.01%	2744
2026 Q2	$27K	Buy	863 +257	+42%	+$6.35K	﹤0.01%	2680
2026 Q1	$12.7K	Buy	606 +129	+27%	+$1.8K	﹤0.01%	2946
2025 Q4	$4.23K	Buy	477 +13	+3%	+$112	﹤0.01%	3354
2025 Q3	$3.9K	Buy	464 +399	+614%	+$2.7K	﹤0.01%	3265
2025 Q2	$333	Buy	+65	New	+$161	﹤0.01%	3680
2024 Q4	–	Sell	-508	Closed	-$3.91K	–	3827
2024 Q3	$3.91K	Buy	508 +438	+626%	+$4.18K	﹤0.01%	2843
2024 Q2	$601	Buy	70 +19	+37%	+$147	﹤0.01%	3171
2024 Q1	$405	Sell	51 -28	-35%	-$300	﹤0.01%	3136
2023 Q4	$928	Buy	+79	New	+$686	﹤0.01%	2810

Other funds holding TNGX

CAM

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing's TNGX Position: Q3 2026 in Review

GAMMA Investing increased its Tango Therapeutics (TNGX) stake by 29% in Q3 2026, buying an estimated $6.46K and bringing the position to 1,111 shares worth $27.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2744.

GAMMA Investing first reported a position in TNGX in Q4 2023 and has held it in 10 quarters since. 3 funds tracked by Wall St. Rank hold TNGX as of Q3 2026.

GAMMA Investing held 1,111 shares of Tango Therapeutics worth $27.7K as of Q3 2026.
GAMMA Investing bought 248 Tango Therapeutics shares in Q3 2026, an estimated $6.46K.
Tango Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2744 holding.
GAMMA Investing first reported a position in Tango Therapeutics in Q4 2023 and has held it in 10 quarters since.
3 funds tracked by Wall St. Rank held Tango Therapeutics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.